A double whammy for the sector?
As expected, the August 30 meeting called by the Department of Pharmaceuticals (DoP) to discuss the Draft Pharmaceutical Policy…
Author
India is an important, big market for us
As Merck prepares for its 350th anniversary due next year, we're 'Fit for 2018' says Dr Stefan Oschmann, Chairman of the Executive…
Draft pharma policy: Old wine in a new bottle?
The Draft Pharma Policy 2017 which was released for comments in mid-August, has an ambitious intent: to make drug pricing 'more…
Surviving serialisation
It was way back in 1963 that the US FDA finalised the first version of Good Manufacturing Practices (GMPs) for finished…
India Pharma Inc’s tryst with destiny continues
As we mark our 71st Independence Day this August 15, how far have we progressed on the medicines security front?
A wake up call for serialisation laggards
Pharma companies exporting to the US market who had their eye on the November 2017 deadline to comply with the US Drug Supply…
FDD Conclave 2017: A congregation of R&D leaders
In an endeavour to encourage research and innovation in the rapidly evolving field of formulation development and drug delivery,…
Racing against the GST deadline
The May update on pharma channel sales was gloomy at best, according to AIOCD PharmaTrac
SPORE is focussed on a specific organ site, such as breast or lung cancer
Dr George R Simon, Professor of Medicine and Section Chief, Translational Research, Department of Thoracic/ Head and Neck Medical…
Dull Q4FY17 could be a blessing in disguise
According to a report from CARE Ratings on the corporate performance of Q4FY17, the pharmaceuticals and drugs sector in India,…